Sirolimus-based immunosuppression for transplant-associated thrombotic microangiopathy.
Edwards
Cedric
C
Division of Nephrology, Department of Medicine, Kidney Research Centre, University of Ottawa, Ottawa, Ontario, Canada.
House
Andrew
A
Shahinian
Vahakn
V
Knoll
Greg
G
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology* / Q000502:physiology; D010956:Plasmapheresis; D010976:Platelet Count; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications*; D011183:Postoperative Complications; D020123:Sirolimus / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D020123:Sirolimus